A Novel Lysophospholipid- and pH-Sensitive Receptor, GPR4, in Brain Endothelial Cells Regulates Monocyte Transmigration

REFERENCES

• Amano M., Ito M., Kimura K., Fukata Y., Chihara K., Nakano T., Matsuura Y., Kaibuchi K. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). Journal of Biological Chemistry 1996; 271: 20246–20249
   PubMed Web of Science ®Google Scholar
• Boguslawski G., Lyons D., Harvey K. A., Kovala A. T., English D. Sphingosylphosphorylcholine induces endothelial cell migration and morphogenesis. Biochemical Biophysical Research Commununications 2000; 272: 603–609
   PubMed Web of Science ®Google Scholar
• Caslake M. J., Packard C. J., Suckling K. E., Holmes S. D., Chamberlain P., Macphee C. H. Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase: A potential new risk factor for coronary artery disease. Atherosclerosis 2000; 150: 413–419
   PubMed Web of Science ®Google Scholar
• Essler M., Amano M., Kruse H. J., Kaibuchi K., Weber P. C., Aepfelbacher M. Thrombin inactivates myosin light chain phosphatase via Rho and its target Rho kinase in human endothelial cells. Journal of Biological Chemistry 1998; 273: 21867–21874
   PubMed Web of Science ®Google Scholar
• Garcia J. G., Lazar V., Gilbert-McClain L. I., Gallagher P. J., Verin A. D. Myosin light chain kinase in endothelium: Molecular cloning and regulation. American Journal of Respiration Cellular and Molecular Biology 1997; 16: 489–494
   PubMed Web of Science ®Google Scholar
• Han K. H., Hong K. H., Ko J., Rhee K. S., Hong M. K., Kim J. J., Kim Y. H., Park S. J. Lysophosphatidylcholine up-regulates CXCR4 chemokine receptor expression in human CD4 T cells. Journal of Leukocyte Biology 2004; 76: 195–202
   PubMed Web of Science ®Google Scholar
• Huang F., Subbaiah P. V., Holian O., Zhang J., Johnson A., Gertzberg N., Lum H. Lysophosphatidylcholine increases endothelial permeability: Role of PKC{alpha} and RhoA cross talk. American Journal of Physiology 2005; 289: L176–L185
   Web of Science ®Google Scholar
• Huang Y. H., Schafer-Elinder L., Wu R., Claesson H. E., Frostegard J. Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism. Clinical and Experimental Immunology 1999; 116: 326–331
   PubMed Web of Science ®Google Scholar
• Imokawa G., Takagi Y., Higuchi K., Kondo H., Yada Y. Sphingosylphosphorylcholine is a potent inducer of intercellular adhesion molecule-1 expression in human keratinocytes. Journal of Investigative Dermatology 1999; 112: 91–96
   PubMed Web of Science ®Google Scholar
• Inoue N., Takeshita S., Gao D., Ishida T., Kawashima S., Akita H., Tawa R., Sakurai H., Yokoyama M. Lysophosphatidylcholine increases the secretion of matrix metalloproteinase 2 through the activation of NADH/NADPH oxidase in cultured aortic endothelial cells. Atherosclerosis 2001; 155: 45–52
   PubMed Web of Science ®Google Scholar
• Kabarowski J. H., Feramisco J. D., Le L. Q., Gu J. L., Luoh S. W., Simon M. I., Witte O. N. Direct genetic demonstration of G alpha 13 coupling to the orphan G protein-coupled receptor G2A leading to RhoA-dependent actin rearrangement. Proceedings of the National Academy of Sciences of the United States of America 2000; 97: 12109–12114
   PubMed Web of Science ®Google Scholar
• Katz A. M., Messineo F. C. Lipid-membrane interactions and the pathogenesis of ischemic damage in the myocardium. Circulation Research 1981; 48: 1–16
   PubMed Web of Science ®Google Scholar
• Kim K. S., Ren J., Jiang Y., Ebrahem Q., Tipps R., Cristina K., Xiao Y. J., Qiao J., Taylor K. L., Lum H., et al. GPR4 plays a critical role in endothelial cell function and mediates the effects of sphingosylphosphorylcholine. FASEB Journal 2005; 19: 819–821
   PubMed Web of Science ®Google Scholar
• Kimura K., Ito M., Amano M., Chihara K., Fukata Y., Nakafuku M., Yamamori B., Feng J., Nakano T., Okawa K., et al. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 1996; 273: 245–248
   PubMed Web of Science ®Google Scholar
• Kougias P., Chai H., Lin P. H., Lumsden A. B., Yao Q., Chen C. Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis. Medical Science Monitor 2006; 12: RA5–R16
   PubMed Web of Science ®Google Scholar
• Kugiyama K., Sugiyama S., Ogata N., Oka H., Doi H., Ota Y., Yasue H. Burst production of superoxide anion in human endothelial cells by lysophosphatidylcholine. Atherosclerosis 1999; 143: 201–204
   PubMed Web of Science ®Google Scholar
• Kume N., Cybulsky M. I., Gimbrone M. A., Jr. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. Journal of Clinical Investigation 1992; 90: 1138–1144
   PubMed Web of Science ®Google Scholar
• Lerm M., Schmidt G., Aktories K. Bacterial protein toxins targeting rho GTPases. FEMS Microbiology Letters 2000; 188: 1–6
   PubMed Web of Science ®Google Scholar
• Lin P., Welch E. J., Gao X. P., Malik A. B., Ye R. D. Lysophosphatidylcholine modulates neutrophil oxidant production through elevation of cyclic AMP. Journal of Immunology 2005; 174: 2981–2989
   PubMed Web of Science ®Google Scholar
• Ludwig M. G., Vanek M., Guerini D., Gasser J. A., Jones C. E., Junker U., Hofstetter H., Wolf R. M., Seuwen K. Proton-sensing G-protein-coupled receptors. Nature 2003; 425: 93–98
   PubMed Web of Science ®Google Scholar
• Lum H., Qiao J., Walter R. J., Huang F., Subbaiah P. V., Kim K. S., Holian O. Inflammatory stress increases receptor for lysophosphatidylcholine in human microvascular endothelial cells. American Journal of Physiology 2003; 285: H1786–H1789
   PubMed Web of Science ®Google Scholar
• Marinetti G. V. Chromatographic separation, identification, and analysis of phosphatides. Journal of Lipid Research 1962; 3: 1–20
   Web of Science ®Google Scholar
• McIntyre T. M., Zimmerman G. A., Prescott S. M. Biologically active oxidized phospholipids [review]. Journal of Biological Chemistry 1999; 274: 25189–25192
   PubMed Web of Science ®Google Scholar
• Mehta D., Tiruppathi C., Sandoval R., Minshall R. D., Holinstat M., Malik A. B. Modulatory role of focal adhesion kinase in regulating human pulmonary arterial endothelial barrier function. Journal of Physiology 2002; 539: 779–789
   PubMed Web of Science ®Google Scholar
• Meyerzu H. D., Himmel H. M., Jakobs K. H. Sphingosylphosphorylcholine-biological functions and mechanisms of action. Biochimica Biophysica Acta 2002; 1582: 178–189
   PubMed Web of Science ®Google Scholar
• Murohara T., Scalia R., Lefer A. M. Lysophosphatidylcholine promotes P-selectin expression in platelets and endothelial cells. Possible involvement of protein kinase C activation and its inhibition by nitric oxide donors. Circulation Research 1996; 78: 780–789
   PubMed Web of Science ®Google Scholar
• Murugesan G., Sandhya Rani M. R., Gerber C. E., Mukhopadhyay C., Ransohoff R. M., Chisolm G. M., Kottke-Marchant K. Lysophosphatidylcholine regulates human microvascular endothelial cell expression of chemokines. Journal of Molecular and Cellular Cardiology 2003; 35: 1375–1384
   PubMed Web of Science ®Google Scholar
• Ousman S. S., David S. Lysophosphatidylcholine induces rapid recruitment and activation of macrophages in the adult mouse spinal cord. Glia 2000; 30: 92–104
   PubMed Web of Science ®Google Scholar
• Qiao J., Huang F., Lum H. PKA inhibits RhoA activation: A protection mechanism against endothelial barrier dysfunction. American Journal of Physiology 2003; 284: L972–L980
   PubMed Web of Science ®Google Scholar
• Qiao J., Huang F., Naikawadi R. P., Kim K. S., Said T., Lum H. Lysophosphatidylcholine impairs endothelial barrier function through the G protein-coupled receptor GPR4. American Journal of Physiology 2006; 291: L91–L101
   PubMed Web of Science ®Google Scholar
• Quinn M. T., Parthasarathy S., Steinberg D. Lysophosphatidylcholine: A chemotactic factor for human monocytes and its potential role in atherogenesis. Proceedings of the National Academy of Sciences of the United States of America 1988; 85: 2805–2809
   PubMed Web of Science ®Google Scholar
• Radu C. G., Yang L. V., Riedinger M., Au M., Witte O. N. T cell chemotaxis to lysophosphatidylcholine through the G2A receptor. Proceedings of the National Academy of Sciences of the United States of America 2004; 101: 245–250
   PubMed Web of Science ®Google Scholar
• Ryborg A. K., Deleuran B., Sogaard H., Kragballe K. Intracutaneous injection of lysophosphatidylcholine induces skin inflammation and accumulation of leukocytes. Acta Dermato-Venereologica 2000; 80: 242–246
   PubMed Web of Science ®Google Scholar
• Saito H., Minamiya Y., Kitamura M., Saito S., Enomoto K., Terada K., Ogawa J. Endothelial myosin light chain kinase regulates neutrophil migration across human umbilical vein endothelial cell monolayer. Journal of Immunology 1998; 161: 1533–1540
   PubMed Web of Science ®Google Scholar
• Saito H., Minamiya Y., Saito S., Ogawa J. Endothelial Rho and Rho kinase regulate neutrophil migration via endothelial myosin light chain phosphorylation. Journal of Leukocyte Biology 2002; 72: 829–836
   PubMed Web of Science ®Google Scholar
• Seufferlein T., Rozengurt E. Sphingosylphosphorylcholine rapidly induces tyrosine phosphorylation of p125FAK and paxillin, rearrangement of the actin cytoskeleton and focal contact assembly. Requirement of p21rho in the signaling pathway. Journal of Biological Chemistry 1995; 270: 24343–24351
   PubMed Web of Science ®Google Scholar
• Sin W. C., Zhang Y., Zhong W., Adhikarakunnathu S., Powers S., Hoey T., An S., Yang J. G protein-coupled receptors GPR4 and TDAG8 are oncogenic and overexpressed in human cancers. Oncogene 2004; 23: 6299–6303
   PubMed Web of Science ®Google Scholar
• Sobel B. E., Corr P. B., Robison A. K., Goldstein R. A., Witkowski F. X., Klein M. S. Accumulation of lysophosphoglycerides with arrhythmogenic properties in ischemic myocardium. Journal of Clinical Investigation 1978; 62: 546–553
   PubMed Web of Science ®Google Scholar
• Stamatovic S. M., Keep R. F., Kunkel S. L., Andjelkovic A. V. Potential role of MCP-1 in endothelial cell tight junction “opening”: Signaling via Rho and Rho kinase. Journal of Cell Science 2003; 116: 4615–4628
   PubMed Web of Science ®Google Scholar
• Stins M. F., Gilles F., Kim K. S. Selective expression of adhesion molecules on human brain microvascular endothelial cells. Journal of Neuroimmunology 1997a; 76: 81–90
   PubMed Web of Science ®Google Scholar
• Stins M. F., Prasadarao N. V., Zhou J., Arditi M., Kim K. S. Bovine brain microvascular endothelial cells transfected with SV40-large T antigen: Development of an immortalized cell line to study pathophysiology of CNS disease [letter]. In Vitro Cellular.& Developmental. Biology Animal 1997b; 33: 243–247
   Web of Science ®Google Scholar
• Takahara N., Kashiwagi A., Maegawa H., Shigeta Y. Lysophosphatidylcholine stimulates the expression and production of MCP-1 by human vascular endothelial cells. Metabolism: Clinical & Experimental 1996; 45: 559–564
   PubMed Web of Science ®Google Scholar
• Takeshita S., Inoue N., Gao D., Rikitake Y., Kawashima S., Tawa R., Sakurai H., Yokoyama M. Lysophosphatidylcholine enhances superoxide anions production via endothelial NADH/NADPH oxidase. Journal of Atherosclerosis and Thrombosis 2000; 7: 238–246
   PubMedGoogle Scholar
• Tinsley J. H., de Lanerolle P., Wilson E., Ma W., Yuan S. Y. Myosin light chain kinase transference induces myosin light chain activation and endothelial hyperpermeability. American Journal of Physiology 2000; 279: C1285–C1289
   PubMed Web of Science ®Google Scholar
• Tomura H., Mogi C., Sato K., Okajima F. Proton-sensing and lysolipid-sensitive G-protein-coupled receptors: A novel type of multi-functional receptors. Cell Signaling 2005; 17: 1466–1476
   PubMed Web of Science ®Google Scholar
• Wojciak-Stothard B., Williams L., Ridley A. J. Monocyte adhesion and spreading on human endothelial cells is dependent on Rho-regulated receptor clustering. Journal of Cell Biology 1999; 145: 1293–1307
   PubMed Web of Science ®Google Scholar
• Xu Y. Sphingosylphosphorylcholine and lysophosphatidylcholine: G protein-coupled receptors and receptor-mediated signal transduction. Biochimica Biophysica Acta 2002; 1582: 81–88
   PubMed Web of Science ®Google Scholar
• Yan S., Chai H., Wang H., Yang H., Nan B., Yao Q., Chen C. Effects of lysophosphatidylcholine on monolayer cell permeability of human coronary artery endothelial cells. Surgery 2005; 138: 464–473
   PubMed Web of Science ®Google Scholar
• Yokoyama K., Ishibashi T., Ohkawara H., Kimura J., Matsuoka I., Sakamoto T., Nagata K., Sugimoto K., Sakurada S., Maruyama Y. HMG-CoA reductase inhibitors suppress intracellular calcium mobilization and membrane current induced by lysophosphatidylcholine in endothelial cells. Circulation 2002; 105: 962–967
   PubMed Web of Science ®Google Scholar
• Zhu Y., Lin J. H., Liao H. L., Verna L., Stemerman M. B. Activation of ICAM-1 promoter by lysophosphatidylcholine: Possible involvement of protein tyrosine kinases. Biochimica Biophysica Acta 1997; 1345: 93–98
   PubMed Web of Science ®Google Scholar